The Relationship Between Time Perspective, Fear of Cancer Recurrence, Rumination, and Catastrophizing in Gastric Cancer Survivors
NCT ID: NCT06606080
Last Updated: 2024-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
340 participants
OBSERVATIONAL
2023-08-10
2024-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of MSD on FCR Among Gastric Cancer Survivors
NCT05606549
E-intervention on Subclinical Fear of Cancer Recurrence
NCT06207006
Fear-focused Self-Compassion Therapy for Young Breast Cancer Patients' Fear of Cancer Recurrence
NCT04965428
Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
NCT03270995
Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence
NCT05922423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18 years or older
* There is no history of recurrent disease or new primary cancer
* Received surgical resection of cancerous tissues or radiotherapy treatment
* Conscious, with normal communication and comprehension ability
* The patients were aware of their own condition and diagnosis, and informedly agreed to participate in this study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ting Wang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ting Wang
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jiangsu
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023540
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.